Trial reportPloS one2020
Behavioral preventive measures and the use of medicines and herbal products among the public in response to Covid-19 in Bangladesh: A cross-sectional study.
Trial report in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 6 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
39 citing papers in PubMed, 6 syntheses or guidelines pooled it.
- Impact of COVID-19 lockdown on smoking and vaping: systematic review and meta-analysis.Public health · 2023Pooled it
- A systematic review of self-medication practice during the COVID-19 pandemic: implications for pharmacy practice in supporting public health measures.Frontiers in public health · 2023Pooled it
- Determinants of willingness to pay for health services: a systematic review of contingent valuation studies.The European journal of health economics : HEPAC : health economics in prevention and care · 2022Pooled it
- Knowledge, Attitudes, and Practices Toward the Prevention of COVID-19 in Bangladesh: A Systematic Review and Meta-Analysis.Frontiers in medicine · 2022Pooled it
- Use of Traditional, Complementary and Integrative Medicine During the COVID-19 Pandemic: A Systematic Review and Meta-Analysis.Frontiers in medicine · 2022Pooled it
- Pooled it
- The Effect of a Global Health Shock on Preventive Drug Intake: Evidence from SHARE 2020-2022 for 15 European Countries.Research square · 2026Article
- Manuscript Title: Regulatory and Implications of Complementary and Alternative Medicine (CAM) Use for Infection Prevention: Insights From the Gulf Cooperation Council (GCC) Countries.Risk management and healthcare policy · 2025Article
- Gender and equity considerations in AMR research: a systematic scoping review.Monash bioethics review · 2024Article
- Patterns of self-medication and intention to seek pharmacist guidance among older adults during the COVID-19 pandemic in Macao: a cross-sectional study.BMC public health · 2024Article
- Evaluation of Herbal Products and Dietary Supplements Use in Patients with Respiratory Diseases Applied to Tertiary Health Institution.Turkish journal of pharmaceutical sciences · 2024Article
- Factors associated with the consumption of medicinal plants for the prevention of COVID-19 in peruvian population: a cross-sectional study.Revista peruana de medicina experimental y salud publica · 2024Article
- Medical Misinformation in Polish on the World Wide Web During the COVID-19 Pandemic Period: Infodemiology Study.Journal of medical Internet research · 2024Article
- Article
- Use of integrative and complementary practices in Brazil during the COVID-19 pandemic.PloS one · 2024Article
- Applications of Dietary Supplements and Aromatherapy for Prophylactic and Treatment Purposes During COVID-19 Pandemic.Turkish journal of pharmaceutical sciences · 2023Article
- Knowledge and attitudes towards herbal and dietary products use during the COVID-19 pandemic.Clinical nutrition open science · 2023Article
- The use of herbal and dietary supplements for COVID-19 prevention: A survey among the public in a Malaysian suburban town.Journal of herbal medicine · 2023Article
- Supplementation use and diet changes during COVID-19 pandemic according to anxiety level and Mediterranean diet adherence.Clinical nutrition ESPEN · 2023Article
- The Effects of Medications and the Roles of Pharmacists on the Recovery of Patients with COVID-19 Infection: An Epidemiological Study from the United Arab Emirates.Healthcare (Basel, Switzerland) · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The present study was conducted to assess the behavioral preventive measures and the use of medicines and herbal foods/products among the public in response to Covid-19. A cross-sectional survey comprised of 1222 participants was conducted from 27 June to 20 July 2020. Kruskal-Wallis test was used to identify the differences in behavioral preventive practices across different demographic categories. To identify the factors associated with the use of preventive medicines and herbal foods/products, multivariable logistic regression was performed. Most participants adopted the recommended preventive practices such as washing hands more frequently (87.5%), staying home more often (85.5%), avoiding crowds (86%), and wearing masks (91.6%). About half of the smokers reported a decreased rate of smoking during the pandemic. Also, 14.8% took medicines, 57.6% took herbal foods/products, and 11.2% took both medicines and herbal foods/products as preventive measure against Covid-19. Arsenicum album, vitamin supplements, and zinc supplements were the most commonly used preventive medicines. Gender, age, and fear of Covid-19 were significantly associated with the use of both preventive medicines and herbal foods/products. For the management of Covid-19 related symptoms, paracetamol, antihistamines, antibiotics, and mineral (zinc and calcium) supplements were used most often. Most participants sought information from non-medical sources while using medicines and herbal products. Moreover, potentially inappropriate and unnecessary use of certain drugs was identified.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.